Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy?

Ahmed HU, Arya M, Freeman A, Emberton M.

Lancet Oncol. 2012 Nov;13(11):e509-17. doi: 10.1016/S1470-2045(12)70388-1. Review.

PMID:
23117005
[PubMed - indexed for MEDLINE]
Free Article
2.

Evaluating localized prostate cancer and identifying candidates for focal therapy.

Sartor AO, Hricak H, Wheeler TM, Coleman J, Penson DF, Carroll PR, Rubin MA, Scardino PT.

Urology. 2008 Dec;72(6 Suppl):S12-24. doi: 10.1016/j.urology.2008.10.004.

PMID:
19095124
[PubMed - indexed for MEDLINE]
3.

Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer.

Washington SL, Bonham M, Whitson JM, Cowan JE, Carroll PR.

BJU Int. 2012 Jul;110(1):50-5. doi: 10.1111/j.1464-410X.2011.10704.x. Epub 2011 Nov 11.

PMID:
22077660
[PubMed - indexed for MEDLINE]
4.

The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.

Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL.

BJU Int. 2012 Jul;110(1):36-42. doi: 10.1111/j.1464-410X.2011.10681.x. Epub 2011 Nov 15.

PMID:
22085203
[PubMed - indexed for MEDLINE]
5.

Small high grade adenocarcinoma of the prostate in radical prostatectomy specimens performed for nonpalpable disease: pathogenetic and clinical implications.

Epstein JI, Carmichael MJ, Partin AW, Walsh PC.

J Urol. 1994 Jun;151(6):1587-92.

PMID:
8189570
[PubMed - indexed for MEDLINE]
6.

[Relation between prostate gland volume and some histological markers of malignancy].

González-Enguita C, Fernández-Aceñero MJ, García-Cardoso JV, López-Pérez L, Manzarbeitia F, Vela-Navarrete R.

Actas Urol Esp. 2012 Feb;36(2):86-90. doi: 10.1016/j.acuro.2011.10.007. Epub 2011 Dec 19. Spanish.

PMID:
22188751
[PubMed - indexed for MEDLINE]
7.

Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate.

Arora R, Koch MO, Eble JN, Ulbright TM, Li L, Cheng L.

Cancer. 2004 Jun 1;100(11):2362-6.

PMID:
15160339
[PubMed - indexed for MEDLINE]
Free Article
8.

Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours.

Corcoran NM, Hovens CM, Hong MK, Pedersen J, Casey RG, Connolly S, Peters J, Harewood L, Gleave ME, Goldenberg SL, Costello AJ.

BJU Int. 2012 Mar;109(5):660-4. doi: 10.1111/j.1464-410X.2011.10543.x. Epub 2011 Sep 2.

PMID:
21895937
[PubMed - indexed for MEDLINE]
9.

Morphometric studies of intra-prostatic volume relationships in localized prostatic cancer.

Häggman M, Nordin B, Mattson S, Busch C.

Br J Urol. 1997 Oct;80(4):612-7.

PMID:
9352701
[PubMed - indexed for MEDLINE]
10.

Simulated required accuracy of image registration tools for targeting high-grade cancer components with prostate biopsies.

van de Ven WJ, Hulsbergen-van de Kaa CA, Hambrock T, Barentsz JO, Huisman HJ.

Eur Radiol. 2013 May;23(5):1401-7. doi: 10.1007/s00330-012-2701-1. Epub 2012 Nov 9.

PMID:
23138386
[PubMed - indexed for MEDLINE]
11.

Tumour growth fraction measured by immunohistochemical staining of Ki67 is an independent prognostic factor in preoperative prostate biopsies with small-volume or low-grade prostate cancer.

Zellweger T, Günther S, Zlobec I, Savic S, Sauter G, Moch H, Mattarelli G, Eichenberger T, Curschellas E, Rüfenacht H, Bachmann A, Gasser TC, Mihatsch MJ, Bubendorf L.

Int J Cancer. 2009 May 1;124(9):2116-23. doi: 10.1002/ijc.24174.

PMID:
19117060
[PubMed - indexed for MEDLINE]
12.

Prostatic microcarcinomas in relation to cancer origin and the evolution to clinical cancer.

McNeal JE.

Cancer. 1993 Feb 1;71(3 Suppl):984-91.

PMID:
8428349
[PubMed - indexed for MEDLINE]
13.

Gleason 6 prostate cancer: serious malignancy or toothless lion?

Lepor H, Donin NM.

Oncology (Williston Park). 2014 Jan;28(1):16-22.

PMID:
24683714
[PubMed - indexed for MEDLINE]
14.

DNA ploidy by image analysis of individual foci of prostate cancer: a preliminary report.

Greene DR, Taylor SR, Wheeler TM, Scardino PT.

Cancer Res. 1991 Aug 1;51(15):4084-9.

PMID:
1855223
[PubMed - indexed for MEDLINE]
Free Article
15.

African-American men with low-grade prostate cancer have higher tumor burdens: results from the Duke Prostate Center.

Tsivian M, Bañez LL, Keto CJ, Abern MR, Qi P, Gerber L, Moul JW, Polascik TJ.

Prostate Cancer Prostatic Dis. 2013 Mar;16(1):91-4. doi: 10.1038/pcan.2012.39. Epub 2012 Oct 2.

PMID:
23032361
[PubMed - indexed for MEDLINE]
16.

Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy.

Miyamoto S, Ito K, Miyakubo M, Suzuki R, Yamamoto T, Suzuki K, Suzuki K, Yamanaka H.

Prostate Cancer Prostatic Dis. 2012 Mar;15(1):75-86. doi: 10.1038/pcan.2011.47. Epub 2011 Oct 11.

PMID:
21986985
[PubMed - indexed for MEDLINE]
17.

The contemporary concept of significant versus insignificant prostate cancer.

Ploussard G, Epstein JI, Montironi R, Carroll PR, Wirth M, Grimm MO, Bjartell AS, Montorsi F, Freedland SJ, Erbersdobler A, van der Kwast TH.

Eur Urol. 2011 Aug;60(2):291-303. doi: 10.1016/j.eururo.2011.05.006. Epub 2011 May 17. Review.

PMID:
21601982
[PubMed - indexed for MEDLINE]
18.

Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features.

Boccon-Gibod LM, Dumonceau O, Toublanc M, Ravery V, Boccon-Gibod LA.

Eur Urol. 2005 Dec;48(6):895-9.

PMID:
16125298
[PubMed - indexed for MEDLINE]
19.

Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria.

Mitsuzuka K, Narita S, Koie T, Kaiho Y, Tsuchiya N, Yoneyama T, Kakoi N, Kawamura S, Tochigi T, Habuchi T, Ohyama C, Arai Y.

BJU Int. 2013 May;111(6):914-20. doi: 10.1111/j.1464-410X.2012.11658.x. Epub 2013 Jan 15.

PMID:
23320782
[PubMed - indexed for MEDLINE]
20.

Do Gleason patterns 3 and 4 prostate cancer represent separate disease states?

Lavery HJ, Droller MJ.

J Urol. 2012 Nov;188(5):1667-75. doi: 10.1016/j.juro.2012.07.055. Epub 2012 Sep 19. Review.

PMID:
22998919
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk